Inactive Instrument
Auspex Pharmaceuticals Inc Stock
Stocks
US05211J1025
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 15-04-22 | Auspex Pharmaceuticals : Teva Pharmaceutical's history of key acquisitions | RE |
| 15-04-22 | Auspex Pharmaceuticals : Teva's turnaround CEO sets sights on $40 billion mega-deal | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Brendan O'Grady
CEO | Chief Executive Officer | 59 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sep Sarshar
BRD | Director/Board Member | 59 | 2009-08-31 |
Rod Ferguson
BRD | Director/Board Member | 69 | 2012-12-31 |
Alex Zisson
BRD | Director/Board Member | 56 | 2013-10-16 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.83% | +2.88% | +55.87% | +69.12% | 69.4B | |
| -1.03% | -0.15% | +9.30% | +74.53% | 57.24B | |
| -1.22% | +2.79% | +24.57% | +99.82% | 57.62B | |
| +2.04% | +1.04% | +28.10% | +36.15% | 43.65B | |
| +5.22% | +9.63% | +22.15% | +106.99% | 44.03B | |
| +4.27% | -4.26% | +198.40% | +750.32% | 38.08B | |
| -1.86% | +11.46% | +26.67% | +61.40% | 36.31B | |
| -3.81% | -11.20% | +86.02% | +73.53% | 32.61B | |
| -2.18% | +5.68% | +36.21% | -0.69% | 25.47B | |
| Average | -0.44% | +2.24% | +54.15% | +141.24% | 44.93B | |
| Weighted average by Cap. | -0.63% | +2.44% | +50.14% | +134.23% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
